Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Anne Gildea during one of many hospital appointments after she was diagnosed with breast cancer. RTÉ
Cancer

Comedian Anne Gildea lays bare cancer experience

Six-month journey of The Nualas performer through breast cancer diagnosis and treatment chronicled in RTÉ2 doc tonight.

THE EXPERIENCE OF comedian and writer Anne Gildea through a breast cancer diagnosis and subsequent treatment is to be chronicled in a documentary on RTÉ2 this evening.

Gildea, a member of comedy trio The Nualas, was diagnosed with aggressive stage three breast cancer treatment last summer. The Nualas group was four months into a tour and the doc shows Gildea attempting to juggle rehearsals and tour dates with her treatment.

Shot over a six-month period, the programme – Breast Cancer: No Laughing Matter – promises to be an unflinching study of Gildea’s reaction to the diagnosis, mastectomy and chemotherapy. Gildea, 45, shared some of her experiences at the weekend with other attendees at the National Conference for Cancer Survivorship, which examined the psychological and physical impact of a cancer diagnosis and treatment, as well as coping strategies for survivors. The conference was organised by the Irish Cancer Society.

No Laughing Matter is directed by Libby McCormack and filmed and produced by Anna Rodgers, who directed and produced the recent documentary MND: The Inside Track about RTÉ broadcaster Colm Murray who is living with Motor Neurone Disease.

  • Breast Cancer: No Laughing Matter is on RTÉ2 tonight at 9.30pm.

Your Voice
Readers Comments
5
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.